Page 87 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 87

張清貿  副教授  Ching-Mao Chang, MD, PhD

               ◼  Position/Affiliation/E-mail
               Position/Affiliation:

               Director,  Division  of  Integrative  Medicine,  Center  for  Traditional
               Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;
               Associate  professor,  School  of  Chinese  Medicine,  National Yang  Ming
               Chiao Tung University, Taipei, Taiwan;

               Associate  professor,  Institute  of  Traditional  Medicine,  National  Yang  Ming  Chiao  Tung
               University, Taipei, Taiwan.
               E-mail: magicbjp@gmail.com


               ◼  Biography
                  Dr.  Ching-Mao  Chang,  M.D.,  Ph.D.  is  a  physician-scientist  specializing  in  Traditional
               Chinese  Medicine  (TCM)  with  a  translational  research  focus  on  the  integrated  therapy  for
               Sjögren’s syndrome (SJS) and Dry Eye Syndrome (DES). He and Autoimmune Disease and

               Dry Eye Syndrome Objective Measurements Lab (AIDDES Lab)  advance integrated TCM
               research,  combining  acupuncture  and  herbal  medicine  to  treat  autoimmune-related  dry  eye
               disorders such as SJS and DES. His clinical trials include TBDESJS (Chun-Y u -Ching-Hua-
               Yin), a herbal decoction shown to improve tear secretion, reduce artificial tear use, and enhance

               sleep quality, and ACUDES, demonstrating that targeted acupuncture at GB20 (Fengchi) and
               BL2 (Zanzhu) significantly alleviates dryness symptoms and improves ocular comfort. His
               current work unites these interventions to explore their effects on Neural–Immune–Lacrimal
               gland pathways and ocular surface stability, employing autonomic analysis, tear proteomics,

               neuroimaging,  and  exosome–miRNA  profiling  to  link  molecular  changes  with  clinical
               outcomes. By integrating rigorous clinical data with molecular evidence, this approach provides
               mechanistic validation, strengthens the scientific foundation of TCM, and paves the way for
               safe, effective, and precision-tailored therapies for patients worldwide.

                  He has contributed multiple Letters to the Editor in leading journals, including Lancet, JAMA,
               JAMA Internal Medicine, and JAMA Oncology, offering critical insights on methodology, trial
               design,  and  clinical  translation  in  rheumatology,  immunology,  and  integrative  medicine.
               Through these works, he has contributed to fostering dialogue between TCM  and Western

               scientific  approaches,  supporting  the  advancement  of  both  clinical  practice  and  research
               methodology on a global scale.









                                                           65
   82   83   84   85   86   87   88   89   90   91   92